Our Vision:

On December 8, 2024, IMF Chief Medical Officer Dr. Joseph Mikhael and myeloma community leaders shared key takeaways from the 66th American Society of Hematology Annual Meeting & Exposition during an IMF-hosted Facebook Live Q&A. In this week’s blog, learn about five major topics in multiple myeloma that they discussed, including new frontline therapies, the growing role of minimal residual disease (MRD) testing, CAR T-cell therapies, and bispecific antibody treatments. The panel discusses research on scaling back treatments to improve quality of life and provides practical advice for patients and care partners on navigating current and emerging therapies. IMF President & CEO, and myeloma patient Yelak Biru wrapped up with a call to action: patients must advocate for their quality-of-life needs as new treatments reach the market. Read the complete blog to gain key insights from this important discussion. READ THE BLOG. 

The International Myeloma Foundation's (IMF) headquarters are in Los Angeles. Our staff in the LA-area is exercising caution and not working due to the high winds, fires, and debris impacting the area. The situation in LA is indeed serious, and the IMF prioritizes the safety and well-being of our team and community. For these reasons, the IMF's InfoLine will not be available from January 8, 2025, to January 10, 2025. LEARN MORE.

In this webinar, IMF Chief Medical Officer Dr. Joseph Mikhael and an expert panel highlighted key takeaways from the 2024 ASH Conference, where over 1,000 myeloma-focused abstracts were presented. Watch the replay to learn about the latest in CAR T-cell therapy, bispecific antibodies, and MRD testing, along with insights into quality of life, real-world data, and health disparities. Hear from patient advocates and support group leaders as they share the patient perspective. WATCH THE REPLAY.

The next Las Voces de Mieloma (Spanish/virtual) Support Group will take place on January, 21, 2025 from 10 am – 11 am PST. The Guest Speaker for this meeting will be Dr. Deniss Diaz, MD, a hematologist/internist in Santo Domingo, the Dominican Republic. Dr. Diaz is a member of the Dominican Medical College, the Dominican Society of Hematology, and the Spanish Society of Latin American Hematology and Hemotherapy, as well as the current President of the Dominican Society of Hematology. He is an adjunct professor at the school of medicine at Pontificia Universidad Madre y Maestra, a physician in residence connected to the hematology department of Salvador B. Gautier Hospiital, and is in participation/training in the transplant unit at the Italian Hospital in Buenos Aires, Argentina. For questions about Las Voces de Mieloma, please email [email protected]. REGISTER NOW. 

El próximo grupo de apoyo de Las Voces de Mieloma (español/virtual) se llevará a cabo el 21 de enero de 2025 de 10 a. m. a 11 a. m. PST. La oradora invitada para esta reunión será la Dra. Deniss Díaz, MD, hematólogo/internista en Santo Domingo, República Dominicana. El Dr. Díaz es miembro del Colegio Médico Dominicano, de la Sociedad Dominicana de Hematología y de la Sociedad Española de Hematología y Hemoterapia Latinoamericana, así como el actual Presidenta de la Sociedad Dominicana de Hematología. Es profesor adjunto de la facultad de medicina de la Pontificia Universidad Madre y Maestra, médico residente vinculado al departamento de hematología del Hospital Salvador B. Gautier y está en participación/capacitación en la unidad de trasplantes del Hospital Italiano de Buenos Aires, Argentina. Si tiene preguntas sobre Las Voces de Mieloma, envíe un correo electrónico a [email protected]. REGÍSTRESE AHORA.

The IMF brought myeloma support group leaders and patients to the hybrid 66th annual meeting of the American Society of Hematology (ASH), an exciting convergence of 30,000 healthcare professionals from around the world. Visit these Support Group Leaders' blogs and vlogs from ASH 2024, in which they share the latest clinical updates in myeloma research, therapies, and practice strategies. VISIT THE WEBSITE.

The IMF’s Miracles for Myeloma Virtual/In-Person 5K Run/Walk will take place on Saturday, March 15, 2025, at 7:00 a.m. EST in Boca Raton, Florida. The race starts and finishes at the Boca Raton Marriott at Boca Center (5150 Town Center Circle). All proceeds from this event will fund the IMF’s life-saving research and work to find a cure. Register to run in person, or from any location in the world. You may also choose to honor a loved one along the Remembrance Path. LEARN MORE.